What does PHARMACIE GODIN do?

PHARMACIE GODIN is a pharmacy in Oudergem. Private Limited, started on 14 November 2014, 1 establishment.

What is the address of PHARMACIE GODIN?

The registered office of PHARMACIE GODIN is located at Tervuurse steenweg 46, 1160 Oudergem.

Is PHARMACIE GODIN still active?

Yes. According to the CBE (2 November 2026) PHARMACIE GODIN is active, legal situation “Normale toestand”, started on 14 November 2014.

Is PHARMACIE GODIN registered on Peppol?

Yes, PHARMACIE GODIN is registered on the Peppol network with ID 0208:0567814640.

What is the enterprise number of PHARMACIE GODIN?

The enterprise number of PHARMACIE GODIN is BE0567814640.

When was PHARMACIE GODIN founded?

PHARMACIE GODIN was founded on 14 November 2014.

Who are the directors of PHARMACIE GODIN?

According to the 2025 annual accounts, the directors of PHARMACIE GODIN are: ANNE GODIN.

Is PHARMACIE GODIN a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 14 November 2014; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account; 1 events from the Belgian Official Gazette processed.

How much profit did PHARMACIE GODIN make in 2025?

PHARMACIE GODIN posted a profit after taxes of € 58,405 in financial year 2025.

What is the revenue of PHARMACIE GODIN?

As a small company, PHARMACIE GODIN is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 146,490.

How many employees does PHARMACIE GODIN have?

According to the 2025 annual accounts, PHARMACIE GODIN has 0.8 full-time equivalents (FTE).

PHARMACIE GODIN (Private Limited) - Oudergem

Dossier PHARMACIE GODIN, printed on 3 November 2026 from databakkes.be/en/0567814640/pharmacie-godin. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

PHARMACIE GODIN from Oudergem, company number BE0567814640, closed financial year 2025 with a result of € 58,405 after tax. For that financial year PHARMACIE GODIN recorded a gross margin of € 146,490 and equity of € 72,845. Compared with financial year 2024, the result moved from € 25,631 to € 58,405. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on May 4, 2026.

What it is worth Growing

€ 72,845

▲ 34% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 58,405

▲ 128% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 123,885

▼ 13% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 40,000 paid out

68 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Wage cost

€ 54,239

▲ 32% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 23,074

▲ € 22,220 vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 2 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 28,992

▼ 40% vs 2024

€ 12,678 is repaid this year. At this pace the long-term loan is gone in ≈ 2 years.

Owed to suppliers

€ 42,920

▼ 3% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 17,310

▲ 55% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 135,379 Gross margin 2022: € 135,379 First fiscal year in the series	€ 150,965 Gross margin 2023: € 150,965 ▲ 12% vs 2022 (€ 135,379) Favourable step	€ 133,753 Gross margin 2024: € 133,753 ▼ 11% vs 2023 (€ 150,965) Unfavourable step	€ 146,490 Gross margin 2025: € 146,490 ▲ 10% vs 2024 (€ 133,753) Favourable step	▲ 10%
Profit after taxes	€ 25,632 Profit after taxes 2022: € 25,632 First fiscal year in the series	€ 28,874 Profit after taxes 2023: € 28,874 ▲ 13% vs 2022 (€ 25,632) Favourable step	€ 25,631 Profit after taxes 2024: € 25,631 ▼ 11% vs 2023 (€ 28,874) Unfavourable step	€ 58,405 Profit after taxes 2025: € 58,405 ▲ 128% vs 2024 (€ 25,631) Favourable step	▲ 128%
Equity	€ 79,934 Equity 2022: € 79,934 First fiscal year in the series	€ 68,809 Equity 2023: € 68,809 ▼ 14% vs 2022 (€ 79,934) Unfavourable step	€ 54,440 Equity 2024: € 54,440 ▼ 21% vs 2023 (€ 68,809) Unfavourable step	€ 72,845 Equity 2025: € 72,845 ▲ 34% vs 2024 (€ 54,440) Favourable step	▲ 34%
Total debts	€ 484,227 Total debts 2022: € 484,227 First fiscal year in the series	€ 278,203 Total debts 2023: € 278,203 ▼ 43% vs 2022 (€ 484,227) Favourable step	€ 253,633 Total debts 2024: € 253,633 ▼ 9% vs 2023 (€ 278,203) Favourable step	€ 242,076 Total debts 2025: € 242,076 ▼ 5% vs 2024 (€ 253,633) Favourable step	▼ 5%
Cash	€ 324,159 Cash 2022: € 324,159 First fiscal year in the series	€ 147,898 Cash 2023: € 147,898 ▼ 54% vs 2022 (€ 324,159) Unfavourable step	€ 142,354 Cash 2024: € 142,354 ▼ 4% vs 2023 (€ 147,898) Unfavourable step	€ 123,885 Cash 2025: € 123,885 ▼ 13% vs 2024 (€ 142,354) Unfavourable step	▼ 13%
Retained profit	€ 61,334 Retained profit 2022: € 61,334 First fiscal year in the series	€ 50,209 Retained profit 2023: € 50,209 ▼ 18% vs 2022 (€ 61,334) Unfavourable step	€ 35,840 Retained profit 2024: € 35,840 ▼ 29% vs 2023 (€ 50,209) Unfavourable step	€ 54,245 Retained profit 2025: € 54,245 ▲ 51% vs 2024 (€ 35,840) Favourable step	▲ 51%
Dividend	€ 40,000 Dividend 2022: € 40,000 First fiscal year in the series	€ 40,000 Dividend 2023: € 40,000 Unchanged (€ 40,000) Unchanged	€ 40,000 Dividend 2024: € 40,000 Unchanged (€ 40,000) Unchanged	€ 40,000 Dividend 2025: € 40,000 Unchanged (€ 40,000) Unchanged
Bank debt	€ 86,675 Bank debt 2022: € 86,675 First fiscal year in the series	€ 67,841 Bank debt 2023: € 67,841 ▼ 22% vs 2022 (€ 86,675) Favourable step	€ 48,618 Bank debt 2024: € 48,618 ▼ 28% vs 2023 (€ 67,841) Favourable step	€ 28,992 Bank debt 2025: € 28,992 ▼ 40% vs 2024 (€ 48,618) Favourable step	▼ 40%
Balance sheet total	€ 564,161 Balance sheet total 2022: € 564,161 First fiscal year in the series	€ 347,012 Balance sheet total 2023: € 347,012 ▼ 38% vs 2022 (€ 564,161) Unchanged	€ 308,073 Balance sheet total 2024: € 308,073 ▼ 11% vs 2023 (€ 347,012) Unchanged	€ 314,922 Balance sheet total 2025: € 314,922 ▲ 2% vs 2024 (€ 308,073) Unchanged	▲ 2%
Employees (FTE)	0.5 Employees (FTE) 2022: 0.5 First fiscal year in the series	0.6 Employees (FTE) 2023: 0.6 ▲ 0.1 vs 2022 (0.5) Unchanged	0.6 Employees (FTE) 2024: 0.6 Unchanged (0.6) Unchanged	0.8 Employees (FTE) 2025: 0.8 ▲ 0.2 vs 2024 (0.6) Unchanged	▲ 0.2

Key figures of PHARMACIE GODIN, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to PHARMACIE GODIN?

What happened at PHARMACIE GODIN in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

May 4, 2026 New annual accounts for financial year 2025: profit of € 58,405 (▲ 128% vs 2024). Source: NBB ↗
Nov 18, 2014 Incorporation, published in the Gazette. Source: Staatsblad ↗
Nov 14, 2014 New establishment in Oudergem. KBO
2014 ANNE GODIN became a director. NBB

In short

From € 25,632 profit in 2022 to € 58,405 profit in 2025.

Paid € 48,241 in corporate taxes since 2022.

Best year ever: 2025, with € 58,405 profit.

Paid out € 160,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

ANNE GODIN

PHARMACIE GODIN

Behind PHARMACIE GODIN is ANNE GODIN.

Directors

According to the 2025 annual accounts

ANNE GODIN

Administrator-manager

since 2014

Establishments

Establishment units

Physical locations of this company

Registered office

Tervuurse steenweg 46

1160 Oudergem

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

SDP Medicals

€ 21,334 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Shareholders according to the Official Gazette deeds

Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.

Incorporation

18 November 2014 Source: Deed ↗

GODIN Anne Simone(oprichter) 100%

Details

Company number: 0567.814.640
VAT number: BE 0567.814.640
Registered office: Tervuurse steenweg 46, 1160 Oudergem
Names & denominations: PHARMACIE GODIN
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 14 November 2014
Peppol: Active · Active since 28 May 2024
Activities · NACE: Detailhandel in farmaceutische producten

View on CBE Public ↗ Annual accounts (NBB) ↗